WATCH NOW
Biogen Webinar | May 2025
On May 22, 2025, Biogen joined FARA for an informational webinar about Biogen’s upcoming BRAVE study: a global phase 3 pediatric study for omaveloxolone.
On May 22, 2025, Biogen joined FARA for an informational webinar about Biogen’s upcoming BRAVE study: a global phase 3 pediatric study for omaveloxolone.